Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

Author:

Henkens M. T. H. M.,Raafs A. G.,Verdonschot J. A. J.,Linschoten M.,van Smeden M.,Wang P.,van der Hooft B. H. M.,Tieleman R.,Janssen M. L. F.,ter Bekke R. M. A.,Hazebroek M. R.,van der Horst I. C. C.,Asselbergs F. W.,Magdelijns F. J. H.,Heymans S. R. B.,Al-Ali A. K.,Al-Muhanna F. A.,Al-Windy N. Y. Y.,Almubarak Y. A.,Alnafie A. N.,Alshahrani M.,Alshehri A. M.,Anthonio R. L.,Asselbergs F. W.,Aujayeb A.,ten Berg J. M.,van Boxem A. J. M.,Captur G.,Caputo M.,Charlotte N.,Dark P.,De Sutter J.,Delsing C. E.,Dorman H. G. R.,Drost J. T.,Emans M. E.,Ferreira J. B.,Gabriel L.,van Gilst W. H.,Groenemeijer B. E.,Haerkens-Arends H. E.,van der Harst P.,Hedayat B.,van der Heijden D. J.,Hellou E.,Hermanides R. S.,Hermans-van Ast J. F.,van Hessen M. W. J.,Heymans S. R. B.,van der Horst I. C. C.,van Ierssel S. H.,Jewbali L. S.,Kearney M. T.,van Kesteren H. A. M.,Kietselaer B. L. J. H.,Koning A. M. H.,Kopylov P. Y.,Kuijper A. F. M.,Kwakkel-van Erp J. M.,van der Linden M. M. J. M.,Linschoten M.,Linssen G. C. M.,Macias Ruiz R.,Magdelijns F. J. H.,Martens F. M. A. C.,McCann G. P.,van der Meer P.,Meijs M. F. L.,Messiaen P.,Monraats P. S.,Montagna L.,Moriarty A.,Mosterd A.,Nierop P. R.,van Ofwegen-Hanekamp C. E. E.,Pinto Y. M.,Poorhosseini H.,Prasad S.,Redón J.,Reidinga A. C.,Ribeiro M. I. A.,Ripley D. P.,Salah R.,Saneei E.,Saxena M.,Schaap J.,Schellings D. A. A. M.,Schut A.,Shafiee A.,Shore A. C.,Siebelink H. J.,van Smeden M.,Smits P. C.,Pisters R.,Tessitore E.,Tieleman R. G.,Timmermans P.,Tio R. A.,Tjong F. V. Y.,den Uil C. A.,Van Craenenbroeck E. M.,van Veen H. P. A. A.,Veneman T.,Verschure D. O.,de Vries J. K.,van de Wal R. M. A.,van de Watering D. J.,Westendorp I. C. D.,Westendorp P. H. M.,Weytjens C.,Wierda E.,Williams B.,Woudstra P.,Wu K. W.,Zaal R.,Zaman A. G.,van der Zee P. M.,

Abstract

Abstract Background Age and comorbidities increase COVID-19 related in-hospital mortality risk, but the extent by which comorbidities mediate the impact of age remains unknown. Methods In this multicenter retrospective cohort study with data from 45 Dutch hospitals, 4806 proven COVID-19 patients hospitalized in Dutch hospitals (between February and July 2020) from the CAPACITY-COVID registry were included (age 69[58–77]years, 64% men). The primary outcome was defined as a combination of in-hospital mortality or discharge with palliative care. Logistic regression analysis was performed to analyze the associations between sex, age, and comorbidities with the primary outcome. The effect of comorbidities on the relation of age with the primary outcome was evaluated using mediation analysis. Results In-hospital COVID-19 related mortality occurred in 1108 (23%) patients, 836 (76%) were aged ≥70 years (70+). Both age 70+ and female sex were univariably associated with outcome (odds ratio [OR]4.68, 95%confidence interval [4.02–5.45], OR0.68[0.59–0.79], respectively;both p<  0.001). All comorbidities were univariably associated with outcome (p<0.001), and all but dyslipidemia remained significant after adjustment for age70+ and sex. The impact of comorbidities was attenuated after age-spline adjustment, only leaving female sex, diabetes mellitus (DM), chronic kidney disease (CKD), and chronic pulmonary obstructive disease (COPD) significantly associated (female OR0.65[0.55–0.75], DM OR1.47[1.26–1.72], CKD OR1.61[1.32–1.97], COPD OR1.30[1.07–1.59]). Pre-existing comorbidities in older patients negligibly (<6% in all comorbidities) mediated the association between higher age and outcome. Conclusions Age is the main determinant of COVID-19 related in-hospital mortality, with negligible mediation effect of pre-existing comorbidities. Trial registration CAPACITY-COVID (NCT04325412)

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology

Reference31 articles.

1. WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: 16-07-2021).

2. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548–51.

3. Wu C, Chen X, Cai Y, Ja X, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA. Intern Med. 2020;180(7):934–43.

4. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–55.

5. NHS Digital. Coronavirus (COVID-19): shielded patients list 2020.

Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3